To further demonstrate the utility of the multiple PAP-fused cytokines, we investigated the in vivo therapeutic effects of the recombinant proteins in a mouse prostate cancer model bearing both PSA- and PAP-expressing tumors. Here, ACP3 is linked to prostate cancer.